HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


California Dreamin’: New York Exploring Prop 65-Like Program For Hazardous Chemical Labeling

Executive Summary

If industry needs further incentive to drive federal cosmetics legislation with robust preemption, New York could have just provided it. The Consumer Chemical Awareness Act, proposed by Governor Cuomo, does not include any mention of a private right of action, but it would pave the way for hazardous chemical labeling à la California's Prop 65 while imposing extensive reporting requirements on industry.

You may also be interested in...

New York's Prop 65-Like Proposal Dropped From Budget, But Talks Continue

Governor Andrew Cuomo’s Consumer Right to Know Act, New York’s answer to Prop 65 in California, was scuttled by legislators in their budget bill signed into law April 12. However, related talks are ongoing in the state’s legislature, where the Safe Cosmetics Act is on the table again this session.

Rep. Pallone’s Discussion Draft For Cosmetics Reform Closely Mirrors Reintroduced Feinstein/Collins Bill

A bipartisan proposal from new House Energy & Commerce chair Frank Pallone and Rep. John Shimkus, R-Ill., is a near-facsimile of the reintroduced Personal Care Products Safety Act in the Senate. This could set the stage for simultaneous consideration and expeditious movement in both chambers of Congress.

PCPC: State Legislation, ‘Fake Science,' FDA’s Sunscreen Monograph Among Top 2019 Challenges

The Personal Care Products Council’s top execs identified key legislative, regulatory and public affairs challenges facing industry in 2019 during a Feb. 26 panel discussion at the group’s annual meeting in Palm Beach, Fla.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts